Wearable devices that measure circadian rest-activity rhythms may be able to assess frailty-related health risks more than six years before an incidence occurs, according to a new study.

New technology gives voice to pathologic changes in neurodegenerative illnesses like Alzheimer’s and epilepsy.

Genetic detective work sheds light on SORL1 gene offering possible new treatments, especially for patients not responsive to existing therapies.

Neurologist explains why recent trial of the drug lecanemab may offer hope for those with deadly disease.

Researchers identified a first-of-its-kind patient with a genetic predisposition for early-onset Alzheimer’s disease who remained cognitively intact more than two decades beyond the expected age of memory impairment.

Authors Andrew Budson and Elizabeth Kensinger offers insights on how to keep both a healthy brain and a strong memory.

The brain of a woman with a family history of early-onset Alzheimer’s disease who lived dementia-free into her 70s is providing researchers with important information about the pathobiology of Alzheimer’s dementia and possible ways to prevent or treat it.

A new study reveals that two newly identified plasma biomarkers of Alzheimer’s disease can predict postoperative delirium, one of the most common postoperative complications in older patients.